Mattessich Antony C.
- SEC CIK
- 0001709900
No open-market purchases or sales filed in the past year.
Current role at each company
- AURA Aura Biosciences, Inc.Directoras of Jun 15, 2026
- OCUL Ocular Therapeutix, IncPresident and CEOas of Feb 6, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mattessich Antony C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OCUL Ocular Therapeutix, Inc
President and CEO5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 (view filing) | Feb 5 | 1 day | Mattessich Antony C.President and CEO | SSale | +19.6K | $4.86 | +$95.5K | +3.5%588.7K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Mattessich Antony C.President and CEO | SSale | −18.3K | $4.95 | −$90.8K | −4.1%427.9K after | |
| Sep 5, 2023 (view filing) | Aug 30 | 6 daysLate | Mattessich Antony C.President and CEO | PPurchase | +6.50K | $3.81 | +$24.8K | New position6.50K after | |
| Feb 8, 2023 (view filing) | Feb 6 | 2 days | Mattessich Antony C.President and CEO | SSale | −19.7K | $4.24 | −$83.4K | −4.2%446.3K after | |
| Aug 24, 2021 (view filing) | Aug 20 | 4 days | Mattessich Antony C.President and CEO | PPurchase | +5.00K | $9.89 | +$49.5K | +5.1%102.9K after |